Clinical Trials Logo

Hypogonadism, Male clinical trials

View clinical trials related to Hypogonadism, Male.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05205837 Terminated - Hypogonadism Clinical Trials

A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

Start date: November 24, 2021
Phase: Phase 4
Study type: Interventional

The overall objective of this randomized trial is to investigate the effects of treatment of AAS- induced male hypogonadism with combined therapy of letrozole and hCG compared with placebo on reproductive hormone levels, adherence to cessation of AAS use, fertility, cardiac function and quality of life.

NCT ID: NCT03335254 Terminated - Hypogonadism Clinical Trials

A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males

Start date: November 6, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This will be a phase 1/2a, open-label, single-center study with 3 periods. The aims of the study are to: 1. evaluate the dose-response curve following ascending single doses of TSX-011; 2. confirm optimum dosing conditions; 3. evaluate the efficacy of single or multiple daily adaptive dosing; and 4. evaluate the safety and tolerability of TSX-011.